日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial

5-HT1A受体激动剂丁螺环酮可改善系统性硬化症患者的食管运动功能和症状:一项为期4周的开放标签试验

Karamanolis, George P; Panopoulos, Stylianos; Denaxas, Konstantinos; Karlaftis, Anastasios; Zorbala, Alexandra; Kamberoglou, Dimitrios; Ladas, Spiros D; Sfikakis, Petros P

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care

利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松联合或不联合放疗治疗原发性纵隔大B细胞淋巴瘤:新兴的标准治疗方案

Vassilakopoulos, Theodoros P; Pangalis, Gerassimos A; Katsigiannis, Andreas; Papageorgiou, Sotirios G; Constantinou, Nikos; Terpos, Evangelos; Zorbala, Alexandra; Vrakidou, Effimia; Repoussis, Panagiotis; Poziopoulos, Christos; Galani, Zacharoula; Dimopoulou, Maria N; Kokoris, Stella I; Sachanas, Sotirios; Kalpadakis, Christina; Dimitriadou, Evagelia M; Siakantaris, Marina P; Kyrtsonis, Marie-Christine; Dervenoulas, John; Dimopoulos, Meletios A; Meletis, John; Roussou, Paraskevi; Panayiotidis, Panayiotis; Beris, Photis; Angelopoulou, Maria K